Reference numberEC/1949/19
Previous numbersCert XV, 227; A06371
TitleScott, David Alymer: certificate of election to the Royal Society
CitationDavid Aylmer Scott made his first contribution to biochemistry when in 1922 he played a prominent role in developing the large scale production of insulin. In 1930 Scott showed that insulin could be obtained in crystalline form by the addition of small amounts of zinc to a solution of the amorphous material. He proved that the crystals of insulin which Abel and his colleagues had originally obtained were the zinc salt of the insulin protein. With A M Fisher, Scott developed protamin zinc insulin in 1936. Later in the same year Scott, with A Charles developed a method for the preparation of lugarin from beef lung, which is now universally used. Scott and Charles were the first to isolate lugarin as the crystalline barium salt.
ProposersFrom General Knowledge. E B Verney
From Personal Knowledge. C H Best; C R Harington; H H Dale; Percival Hartley; F J W Roughton; D Keilin; A R Todd; Harold King
Access statusOpen

Scott, David Alymer: certificate of election to the Royal Society

Fellows associated with this archive
NA553Scott; David Alymer (1892 - 1971)1892 - 1971
Add to My Items

    Collection highlights

    Browse the records of some of our collections, which cover all branches of science and date from the 12th century onwards. These include the published works of Fellows of the Royal Society, personal papers of eminent scientists, letters and manuscripts sent to the Society or presented at meetings, and administrative records documenting the Society's activities since our foundation in 1660.

    The Royal Society

    The Royal Society is a Fellowship of many of
    the world's most eminent scientists and is the
    oldest scientific academy in continuous existence.
    Registered charity number 207043

    Website design ©CalmView


    + 44 207 451 2500
    (Lines open Mon-Fri, 9:00-17:00. Excludes bank holidays)

    6-9 Carlton House Terrace, London SW1Y 5AG

    Email Us →


    Subscribe to our newsletters to be updated with the
    latest news on innovation, events, articles and reports.

    Subscribe →

    © CalmView